Found: 2
Select item for more details and to access through your institution.
In vitro dendritic cell generation and lymphocyte subsets in myeloma patients: influence of thalidomide and high-dose chemotherapy treatment.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 5, p. 506, doi. 10.1007/s00262-004-0633-6
- By:
- Publication type:
- Article
Thalidomide in combination with dexamethasone for pretreated patients with multiple myeloma: serum level of soluble interleukin-2 receptor as a predictive factor for response rate and for survival.
- Published in:
- Annals of Hematology, 2005, v. 84, n. 9, p. 594, doi. 10.1007/s00277-005-1007-7
- By:
- Publication type:
- Article